Hettiarachchi, G., Samanta, S. K., Falcinelli, S., Zhang, B., Moncelet, D., Isaacs, L., & Briken, V. (2016). Acyclic cucurbit[n]uril-type molecular container enables systemic delivery of effective doses of albendazole for treatment of SK-OV-3 xenograft tumors. Mol Pharm.

Hettiarachchi, Gaya, Soumen K. Samanta, Shane Falcinelli, Ben Zhang, Damien Moncelet, Lyle Isaacs, and Volker Briken. "Acyclic Cucurbit[n]uril-type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors." Mol Pharm 2016.

Hettiarachchi, Gaya, et al. "Acyclic Cucurbit[n]uril-type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors." Mol Pharm 2016.